However, we would expect full donor chimerism in patients who achieved early complete remission and the appearance of recipient cells would be indicative of early stage leukemia relapse and could require treatment (9–11) with DLIs, anti-CD19 CAR-T reinfusion or a second HSCT. This evidence concerns the gene CD19 and leukemia.